Persons with Diabetes will Contribute to Assess the Global Impact of Telemedicine Services

Diabetes mellitus affects more than 366 million patients worldwide, according to the International Diabetes Federation (IDF), but the prevalence and incidence of the disease are still growing in conjunction with increased obesity rates and sedentary lifestyle. It is projected that in the next 20 years more than one in ten adults will be affected by diabetes. However, the most important issue is that the disease, although silent, is associated with serious complications. Diabetes is the leading cause of cardiovascular diseases including stroke, end-stage renal disease, blindness and amputation. It is also responsible for more than 4.6 million deaths per year. The attendant economic burden for health-care systems and individual patients is enormous, owing to the costs associated with treatment and diabetes complications.

The International Diabetes Federation (IDF) has proposed a National Diabetes Programme with three core elements:
a) Primary prevention: preventing the development of risk factors;
b) Secondary prevention: preventing the development of diabetes; and finally
c) Tertiary prevention: preventing the development of complications through early diagnosis and effective monitoring, treatment and care of people with diabetes.

Telemedicine can contribute significantly in tertiary prevention by providing an effective approach for coaching-education about the disease, improving compliance with medication and recommendations, supporting timely transmission and remote interpretation of patients' data for follow-up and preventive interventions, and finally meeting safely the target for glycaemic control.

Small clinical trials of different telehealth services have shown neutral or positive results in glycaemic control, hospitalizations and quality of life, but in the UK an evaluation of the Whole System Demonstrator trial reported that telecare improves at least quality of life and independence in a cohort of patients including diabetics. However, further research is required to give a more precise assessment of telemedicine applications and this is what the project Renewing Health is about.

RENEWING HEALTH (www.renewinghealth.eu) is a project co-funded by the European Commission. It will evaluate whether the introduction of telemedicine applications to patients with Type 2 diabetes, both with and without health counselling, produces benefits in terms of clinical outcomes such as HbA1c, health-related quality of life (HRQoL), self-management and empowerment.

In addition, the economic and organisational impact of the new services will be assessed, together with their acceptability by patients and health professionals. More than 1.800 diabetics have already been recruited. Recruitment will be completed by the end of the year, and the first results are scheduled to be reported at the end of 2013.

A description of all services under evaluation can be found at: www.renewinghealth.eu/en/services

About RENEWING HEALTH
RENEWING HEALTH is the largest project ever launched in Europe for evaluating the impact of telemedicine in the management of chronic patients in home settings. It is a multicenter randomized clinical trial, partially funded by EU, designed for the evaluation of telemedicine in three main pathologies: heart failure, COPD, and diabetes. The target population is about 7148 patients, with more than 2000 diabetics and a one year follow-up.

In fact, the project expands a variety of pre-existing telemonitoring and health coaching services with the objective to produce high level evidence for healthcare authorities and the medical community and to support future adoption of the services into routine clinical practice.

The Regions which contributes to the project are:

  • Veneto (Italy)
  • Syddanmark (Denmark)
  • Norrbotten (Sweden)
  • Northern Norway (Norway)
  • Catalonia (Spain)
  • South Karelia (Finland)
  • Thessaly (Greece)
  • Carinthia (Austria)
  • Berlin (Germany)

They are supported by these European associations

  • European Patient's Forum
  • European Health Telematics Association
  • Continua Health Alliance

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...